title: [Comparison of ADA and WHO diagnostic criteria for diabetes diagnosis and other categories of glucose intolerance ].
abstract: New diagnostic criteria for diabetes mellitus announced by ADA in 1997 and WHO in 1998 recommend lowering of the fasting plasma glucose to 7.0 mmol/l and introduce new category: impaired fasting glucose. In contrast to ADA, WHO recommends to maintain oral glucose tolerance test in clinical practice. In this study, based on oral glucose tolerance test results and WHO 1998 criteria we estimated diagnostic value of fasting glucose in diagnosing diabetes. The aim of the study was also to compare prevalence of diabetes and other categories of glucose intolerance according to ADA 1997, WHO 1985 and WHO 1998 criteria.
  
  
  METHODS
  Oral glucose tolerance test (OGTT) was performed in 1528 patients (785 men, 743 women). According to ADA 1997, WHO 1985 and WHO 1998 criteria the patients were divided into groups depending on glucose tolerance abnormalities.
  
  
  RESULTS
  Prevalence of diabetes according to ADA 1997 and WHO 1985 criteria was almost the same, being 10.47% and 10.34%, respectively, and according to WHO 1998 criteria it was 13.15%. In 20.4% of all the patients with diabetes according to WHO 1998 criteria, the diagnosis was made on the basis of 2-h post load glucose, in case of WHO 1985 criteria the percentage was 39.9%. 13.04% of patients with IFG according to ADA had diabetes and 34.06% had IGT according to WHO 1998 criteria. The highest overall percentage agreement (97.19%) was found between WHO 1998 and WHO 1985 classifications with the hypothesis that unclassified group according to WHO 1985 corresponds to IFG group according to WHO 1998.
  
  
  CONCLUSIONS
  Despite lower diagnostic value of 2-hour post-load glycaemia in diagnosing diabetes according to WHO 1998 criteria compared to WHO 1985 criteria, OGTT remains irreplaceable diagnostic tool, especially in high risk populations. In patients with IFG according to ADA OGTT causes significant improvement in detecting diabetes.
authors.affiliation: Klinika Chorób Wewnetrznych PAM w Szczecinie.
authors.forename: Edyta
authors.initials: E
authors.lastname: Herdzik
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Safranow
authors.forename: Kazimierz
authors.initials: K
authors.lastname: Ciechanowski
authors.forename: Elzbieta
authors.initials: E
authors.lastname: Byra
authors.forename: Urszula
authors.initials: U
authors.lastname: Gołdyn
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology; D005260:Female; D018149:Glucose Intolerance / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology; D005951:Glucose Tolerance Test / Q000379:methods / Q000592:standards; D006801:Humans; D008297:Male; D011044:Poland / Q000453:epidemiology; D011159:Population Surveillance / Q000379:methods; D015995:Prevalence; D012372:ROC Curve; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D014837:Voluntary Health Agencies; D014944:World Health Organization
chemical_list: D001786:Blood Glucose